A Study of Enzalutamide Re-treatment in Metastatic Castration-resistant Prostate Cancer After Docetaxel and/or Cabazitaxel Treatment
Clinical trial NCT02441517 · TERMINATED
Trial details
- NCT number
- NCT02441517
- Sponsor
- Astellas Pharma Global Development, Inc.
- Status
- TERMINATED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2015-10-28
- Primary completion
- 2017-03-15
- Enrollment
- 4
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.